Tumor necrosis factor-alpha serum level in assessment of disease activity in inflammatory bowel diseases.

Abstract

Since there were no differences in serum TNF-α concentrations related to the disease activity we consider that TNF-α is not an adequate serum biomarker for an assessment of the disease activity in patients with IBD.